Thomas H. Lee, MD
Carbon22 Chief Medical Officer
Dr. Lee has been active in education and research with over 70 peer reviewed
publications and was a co recipient for the prestigious Roger Mann Award for best paper for his work
with the STAR Total Ankle. He has worked closely with several extremity companies as a design
surgeon.
His innovative development work has included partnerships with Wright Medical
Corporation (Inbone TAR, Infinity TAR, Prophecy CT guided targeting, Valor IM Nail, 3di Fracture
Systems, 3di forefoot plating, Claw plating system, Darco Titanium plating system, Charcot frame
system), Stryker Corporation (Sonic Anchor system, Jones Fracture Screw system).
He has also been an active co-owner in start up Orthopedic companies including
Nexa Corporation (sold to Tornier), Darco Corporation (sold to Wright Medical), Therics Biologics
(sold to Theken), Bledsoe Corporation (sold to Breg corporation), and Surgical Care Affiliates (sold
to Aetna). He is currently active in hospital and orthopedic development within China, India, and
Brazil.